Phycocyanin protects against Alpha-Synuclein toxicity in yeast

Citation data:

Journal of Functional Foods, ISSN: 1756-4646, Vol: 38, Page: 553-560

Publication Year:
2017
Usage 10
Abstract Views 10
Captures 9
Readers 9
Social Media 212
Shares, Likes & Comments 212
DOI:
10.1016/j.jff.2017.09.044
Author(s):
Diana Macedo; Telma Elita Bertolin; Tatiana Oro; Luana Taís Hartmann Backes; Inês Caldeira Brás; Cláudia Nunes Santos; Sandra Tenreiro; Tiago Fleming Outeiro
Publisher(s):
Elsevier BV
Tags:
Agricultural and Biological Sciences; Medicine; Nursing
article description
Parkinson’s disease (PD) is an age-related neurodegenerative disorder associated with the misfolding and aggregation of alpha-synuclein (aSyn) in proteinaceous inclusions. These inclusions are common to a wider spectrum of disorders known as synucleinopathies. While the molecular bases of PD are still unclear, oxidative stress and impairment of protein quality-control systems play an important role, and are regarded as valuable targets for therapeutic interventions. We employed a yeast model of synucleinopathies to test the cytoprotective potential of phycocyanin, a biliprotein used as a nutritional supplement. We found that phycocyanin effectively protected against aSyn toxicity in yeast and, importantly, the mechanism of action involves the reduction of aSyn inclusions and superoxide levels, through the regulation of genes and enzymes involved in oxidative stress response, glutathione metabolism, and cellular protein quality-control systems. Overall, this study highlights the potential of phycocyanin as a nutraceutical in neurodegenerative diseases associated with proteotoxicity, such as synucleinopathies.